Study finds aspirin reduces colon cancer risk, with benefits varying by lifestyle factors

FHS
August 7, 2024
10:32 pm

Aspirin can reduce colorectal cancer risk, but its effectiveness varies based on lifestyle factors such as diet, BMI, and smoking. Personalized recommendations are crucial to identify those who would benefit most from aspirin use.

Venatorx and Menarini sign commercial deal for antibiotic

Share this article Menarini will obtain the sole rights for the marketing of the antibiotic. Credit: fizkes / Shutterstock.com. Venatorx Pharmaceuticals and the Menarini Group

January 10, 2024

Millions of Americans affected by secondhand harm from substance use

The risks of alcohol and other drug consumption to the user are well known, but many Americans–nearly 160 million–say they’ve been harmed by someone else’s

November 21, 2024

Recapping the Endpoints 100: The biotech industry braces itself for Trump 2.0

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.